Journal article
The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI
Abstract
OBJECTIVE: Secondary analyses of a previously conducted 1-year randomized controlled trial were performed to assess the application of responder criteria in patients with knee osteoarthritis (OA) using different sets of responder criteria developed by the Osteoarthritis Research Society International (OARSI) (Propositions A and B) for intra-articular drugs and Outcome Measures in Arthritis Clinical Trials (OMERACT)-OARSI (Proposition D).
Authors
Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld J-P; Torrance GW; Tugwell P; Polisson R
Journal
Osteoarthritis and Cartilage, Vol. 13, No. 2, pp. 104–110
Publisher
Elsevier
Publication Date
February 2005
DOI
10.1016/j.joca.2004.10.016
ISSN
1063-4584